ClinConnect ClinConnect Logo
Search / Trial NCT06765369

How the Mediterranean Diet Affects You: Predicting Responses Based on Your Microbiome

Launched by UNIVERSITY OF BRITISH COLUMBIA · Jan 2, 2025

Trial Information

Current as of August 20, 2025

Not yet recruiting

Keywords

Healthy Individuals Mediterranean Diet Westernized Diet Predictive Microbiome

ClinConnect Summary

This clinical trial is looking at how the Mediterranean diet affects people and aims to tailor dietary recommendations based on individual gut bacteria, known as the microbiome. Researchers want to find out if certain types of gut microbes can predict who will benefit most from following this healthy diet compared to a typical Western diet. Participants will receive all their meals and snacks for the study, which will help the team accurately assess how each diet impacts their microbiome.

To join the study, you need to be a healthy adult between the ages of 20 and 50, with a body mass index (BMI) between 20 and 25, and currently not following the Mediterranean diet very closely. You must live in the Okanagan area and have no history of certain health conditions, like diabetes or bowel diseases. If you take antibiotics, have food allergies, or are pregnant or breastfeeding, you won't be eligible. Participants can expect to enjoy meals provided by the study while contributing to important research that could help create personalized diet plans for better health outcomes.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Healthy participants, defined as free from cardiovascular disease, diabetes, and hypertension
  • Body Mass Index of 20-25
  • Between the ages 20-50 years
  • Low adherence to the Mediterranean diet (MD serving score \[MDSS\] less than 10 points).
  • Must live in the Okanagan area
  • Exclusion Criteria:
  • Individuals with a self-reported history of irritable bowel syndrome, inflammatory bowel disease, Type-2 diabetes, kidney disease, intestinal obstruction, infectious gastroenteritis, colitis or gastritis, Clostridium difficile infection (recurrent) or Helicobacter pylori infection (untreated), malabsorption (such as celiac disease), major surgery of the GI tract, or colorectal cancer
  • Oral antibiotics within three months of the intervention start date
  • Individuals with any known food allergies, reported dietary intolerances of any kind, and those with eating disorders
  • Pregnant or breastfeeding
  • Participants with a high MDSS (\> 10 points)
  • Individuals who are intermittent fasting or refuse to follow the study protocol

About University Of British Columbia

The University of British Columbia (UBC) is a leading research institution located in Vancouver, Canada, renowned for its commitment to advancing health sciences through innovative research and education. As a prominent clinical trial sponsor, UBC leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes across various medical fields. The university fosters collaborations with healthcare professionals, industry partners, and community stakeholders to translate research findings into practical applications, thereby contributing to the global advancement of medicine and public health.

Locations

Kelowna, British Columbia, Canada

Patients applied

0 patients applied

Trial Officials

Natasha Haskey, RD PHD

Principal Investigator

University of British Columbia

Maitreyi Raman, MSc MD FRCPC

Principal Investigator

University of Calgary

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported